HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Tsuda Selected Research

Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)

6/2013The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.
1/2013Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.
2/2012Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor.
10/2011Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Tsuda Research Topics

Disease

182Neoplasms (Cancer)
10/2023 - 01/2002
103Breast Neoplasms (Breast Cancer)
03/2024 - 01/2002
42Carcinoma (Carcinomatosis)
12/2022 - 01/2002
32Neoplasm Metastasis (Metastasis)
08/2023 - 05/2002
26Adenocarcinoma
01/2021 - 04/2002
19Lymphatic Metastasis
08/2023 - 06/2005
16Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 05/2006
12Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 02/2005
11Carcinogenesis
06/2017 - 12/2005
8Triple Negative Breast Neoplasms
11/2020 - 01/2009
8Stomach Neoplasms (Stomach Cancer)
08/2014 - 02/2005
8Clear Cell Adenocarcinoma
06/2012 - 07/2002
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 05/2002
7Endometrial Neoplasms (Endometrial Cancer)
04/2022 - 07/2007
7Ductal Carcinoma
03/2019 - 05/2005
7Squamous Cell Carcinoma of Head and Neck
03/2016 - 06/2005
7Adenocarcinoma of Lung
09/2012 - 07/2007
6Noninfiltrating Intraductal Carcinoma (DCIS)
01/2024 - 05/2005
6Endometriosis
05/2020 - 02/2008
6Lung Neoplasms (Lung Cancer)
10/2014 - 12/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014 - 07/2007
5Ovarian Epithelial Carcinoma
09/2021 - 07/2002
5Adenoma (Adenomas)
06/2013 - 04/2002
4Margins of Excision
08/2023 - 01/2015
4Seminoma
12/2021 - 09/2010
4Endometrioid Carcinoma
10/2020 - 07/2002
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2013 - 10/2011
3Ureteral Neoplasms (Ureteral Cancer)
08/2023 - 07/2021
3Pelvic Neoplasms
08/2023 - 07/2021
3Inflammation (Inflammations)
01/2023 - 07/2010
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2016
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
02/2021 - 07/2002
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2014 - 09/2010
3Pathologic Complete Response
02/2013 - 01/2006

Drug/Important Bio-Agent (IBA)

60Proteins (Proteins, Gene)FDA Link
08/2023 - 06/2002
33Hormones (Hormone)IBA
11/2020 - 01/2002
24ErbB Receptors (EGF Receptor)IBA
03/2024 - 12/2003
24Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2007
22Estrogen ReceptorsIBA
05/2023 - 01/2008
16Messenger RNA (mRNA)IBA
01/2022 - 03/2002
16Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 01/2008
16Phenobarbital (Luminal)FDA Link
01/2022 - 06/2005
15human ERBB2 proteinIBA
05/2023 - 08/2009
15Formaldehyde (Formol)FDA Link
04/2022 - 12/2003
15DNA (Deoxyribonucleic Acid)IBA
03/2014 - 06/2002
12ParaffinIBA
04/2022 - 12/2003
12Indicators and Reagents (Reagents)IBA
01/2022 - 05/2002
9Phosphotransferases (Kinase)IBA
09/2018 - 07/2006
9Trastuzumab (Herceptin)FDA Link
08/2014 - 01/2006
8Nucleic AcidsIBA
01/2022 - 08/2007
8Paclitaxel (Taxol)FDA LinkGeneric
09/2021 - 05/2006
7TamoxifenFDA LinkGeneric
03/2014 - 10/2007
6Cisplatin (Platino)FDA LinkGeneric
01/2023 - 05/2006
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2021 - 01/2005
6PlatinumIBA
01/2021 - 12/2006
6taxaneIBA
01/2020 - 07/2009
6Anaplastic Lymphoma KinaseIBA
09/2013 - 10/2011
5Keratin-19 (Keratin 19)IBA
01/2022 - 08/2007
5MesothelinIBA
10/2021 - 03/2019
5Fluorouracil (Carac)FDA LinkGeneric
02/2021 - 01/2005
5Docetaxel (Taxotere)FDA Link
02/2012 - 01/2005
4Protein Isoforms (Isoforms)IBA
08/2023 - 12/2007
4ActininIBA
08/2023 - 12/2007
4Therapeutic UsesIBA
01/2023 - 07/2009
4SteroidsIBA
01/2022 - 01/2011
4Eosine Yellowish-(YS) (Eosin)IBA
03/2021 - 07/2010
4AnthracyclinesIBA
01/2020 - 08/2009
4AntigensIBA
01/2015 - 04/2006
4EnzymesIBA
02/2014 - 10/2007
4Estrogens (Estrogen)FDA Link
12/2013 - 01/2011
3LigandsIBA
12/2022 - 02/2008
3Carboplatin (JM8)FDA LinkGeneric
09/2021 - 08/2007
3UracilIBA
02/2021 - 10/2007
3TegafurIBA
02/2021 - 10/2007
3Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2021 - 06/2019
3Growth Factor ReceptorsIBA
11/2020 - 07/2004
3Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2020 - 03/2019
3Calcibiotic Root Canal SealerIBA
09/2020 - 02/2005
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2019 - 04/2008
3Complementary DNA (cDNA)IBA
12/2013 - 05/2006
3Rituximab (Mabthera)FDA Link
11/2013 - 10/2012
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2013 - 11/2003
3ProteomeIBA
01/2013 - 05/2011
3Cyclin AIBA
11/2012 - 11/2009
3Cyclin EIBA
11/2012 - 11/2009
3ProgesteroneFDA LinkGeneric
08/2012 - 01/2011

Therapy/Procedure

56Therapeutics
01/2024 - 06/2002
35Drug Therapy (Chemotherapy)
03/2024 - 01/2002
24Neoadjuvant Therapy
01/2020 - 01/2002
10Adjuvant Chemotherapy
05/2023 - 12/2006
9Lasers (Laser)
10/2023 - 04/2002
8Segmental Mastectomy (Lumpectomy)
01/2022 - 03/2002
7Radiotherapy
01/2022 - 05/2002
6Lymph Node Excision (Lymph Node Dissection)
05/2017 - 05/2002
4Mastectomy (Mammectomy)
08/2019 - 01/2011
4Hysterectomy
10/2012 - 05/2002
4Radiofrequency Ablation
01/2011 - 01/2011
3Aftercare (After-Treatment)
10/2023 - 08/2007
3Radical Mastectomy
03/2019 - 01/2011
3Modified Radical Mastectomy (Mastectomy, Modified)
03/2019 - 10/2006